1st Quarter - Amendment — THE MICHAEL J. FOX FOUNDATION FOR PARKI… for THE MICHAEL J. FOX FOUNDATION FOR PARKI… (2021)

Firm

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Client

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Income

—

Expenses

$70,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 19, 2021	$25,000	Replaced
1st Quarter - Amendment (this page)	Jul 28, 2021	$70,000	Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding for the 2022 Appropriations bill including requests for: Department of Defense National Institutes of Health Centers for Disease Control and Prevention Food and Drug Administration

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS)

Agriculture AGR

General education on chemicals that cause Parkinson's disease, including TCE, paraquat, and others.

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Environment/Superfund ENV

Education around environmental causes of neurological disease and support for more research.

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE

Pharmacy PHA

General education around pharmaceuticals related to Parkinson's disease

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Health Issues HCR

General Parkinson's disease information about symptoms, causes, health coverage, and health costs Advocating for Parkinson's patients during Covid-19

Lobbyist	Covered position, as disclosed
AARON POLACEK New	Public Policy Officer

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA)

Medicare/Medicaid MMM

Telehealth flexibilities and making current telehealth rules permanent Medicare Part D design and benefits S.464/H.R.2163, the Safe Step Act of 2021 S.828/H.R.432, the Mental Health Access Improvement Act H.R.2080, the Seniors Access to Vaccine Ensured Act

Lobbyist	Covered position, as disclosed
AARON POLACEK	Associate Director, Public Policy

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Bills named: S. 828 (117th), S. 464 (117th), H.R. 2163 (117th), H.R. 432 (117th), H.R. 2080 (117th)

Veterans VET

General education regarding impacts of the Department of Defense's medical research programs and impact on veterans.

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: SENATE; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.